ATE351906T1 - Zur modulation der krebszellenproliferation geeignetes polynukleotid - Google Patents
Zur modulation der krebszellenproliferation geeignetes polynukleotidInfo
- Publication number
- ATE351906T1 ATE351906T1 AT02748337T AT02748337T ATE351906T1 AT E351906 T1 ATE351906 T1 AT E351906T1 AT 02748337 T AT02748337 T AT 02748337T AT 02748337 T AT02748337 T AT 02748337T AT E351906 T1 ATE351906 T1 AT E351906T1
- Authority
- AT
- Austria
- Prior art keywords
- cell proliferation
- cancer cell
- modulating cancer
- polynucleotide suitable
- modulating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0102801A FR2821624B1 (fr) | 2001-03-01 | 2001-03-01 | Nouveau polynucleotide utilisable pour moduler la proliferation des cellules cancereuses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE351906T1 true ATE351906T1 (de) | 2007-02-15 |
Family
ID=8860611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02748337T ATE351906T1 (de) | 2001-03-01 | 2002-03-01 | Zur modulation der krebszellenproliferation geeignetes polynukleotid |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7214533B2 (de) |
| EP (1) | EP1368474B1 (de) |
| JP (1) | JP4190291B2 (de) |
| KR (1) | KR100869190B1 (de) |
| CN (1) | CN1289670C (de) |
| AT (1) | ATE351906T1 (de) |
| AU (1) | AU2002335492B2 (de) |
| BR (1) | BR0207253A (de) |
| CA (1) | CA2437535C (de) |
| CZ (1) | CZ20032670A3 (de) |
| DE (1) | DE60217651T2 (de) |
| ES (1) | ES2279877T3 (de) |
| FR (1) | FR2821624B1 (de) |
| HK (1) | HK1065334A1 (de) |
| HU (1) | HUP0303312A3 (de) |
| IL (1) | IL157091A0 (de) |
| MX (1) | MXPA03007694A (de) |
| NZ (1) | NZ527261A (de) |
| PL (1) | PL204844B1 (de) |
| RU (1) | RU2307666C2 (de) |
| WO (1) | WO2002070700A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2761717A1 (en) | 2009-05-11 | 2010-11-18 | Berg Biosystems, Llc | Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| AU2012240222B2 (en) | 2011-04-04 | 2017-04-27 | Berg Llc | Methods of treating central nervous system tumors |
| MX2015014097A (es) | 2013-04-08 | 2016-06-07 | Berg Llc | Tratamiento de cancer empleando terapias combinadas de coenzima q10. |
| IL276423B2 (en) | 2013-09-04 | 2024-05-01 | Berg Llc | Pharmaceutical preparations containing coenzyme Q10 for use in cancer treatment |
| JP6863891B2 (ja) * | 2014-11-14 | 2021-04-21 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 調節性ポリヌクレオチド |
| BR112018073472A2 (pt) * | 2016-05-18 | 2019-08-27 | Voyager Therapeutics Inc | composições e métodos de tratamento da doença de huntington |
| IL302748A (en) | 2016-05-18 | 2023-07-01 | Voyager Therapeutics Inc | modulatory polynucleotides |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5637456A (en) * | 1995-02-17 | 1997-06-10 | The University Of Texas, Board Of Regents | Rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
| WO2000069454A1 (en) * | 1999-05-17 | 2000-11-23 | Board Of Regents, The University Of Texas System | Suppression of endogenous igfbp-2 to inhibit cancer |
-
2001
- 2001-03-01 FR FR0102801A patent/FR2821624B1/fr not_active Expired - Fee Related
-
2002
- 2002-03-01 AU AU2002335492A patent/AU2002335492B2/en not_active Ceased
- 2002-03-01 AT AT02748337T patent/ATE351906T1/de not_active IP Right Cessation
- 2002-03-01 US US10/467,436 patent/US7214533B2/en not_active Expired - Fee Related
- 2002-03-01 PL PL365226A patent/PL204844B1/pl not_active IP Right Cessation
- 2002-03-01 EP EP02748337A patent/EP1368474B1/de not_active Expired - Lifetime
- 2002-03-01 ES ES02748337T patent/ES2279877T3/es not_active Expired - Lifetime
- 2002-03-01 CN CNB02805623XA patent/CN1289670C/zh not_active Expired - Fee Related
- 2002-03-01 CZ CZ20032670A patent/CZ20032670A3/cs unknown
- 2002-03-01 DE DE60217651T patent/DE60217651T2/de not_active Expired - Lifetime
- 2002-03-01 BR BR0207253-0A patent/BR0207253A/pt not_active Application Discontinuation
- 2002-03-01 CA CA2437535A patent/CA2437535C/fr not_active Expired - Fee Related
- 2002-03-01 WO PCT/FR2002/000740 patent/WO2002070700A1/fr active IP Right Grant
- 2002-03-01 KR KR1020037011444A patent/KR100869190B1/ko not_active IP Right Cessation
- 2002-03-01 HU HU0303312A patent/HUP0303312A3/hu unknown
- 2002-03-01 RU RU2003129163/13A patent/RU2307666C2/ru not_active IP Right Cessation
- 2002-03-01 JP JP2002570725A patent/JP4190291B2/ja not_active Expired - Lifetime
- 2002-03-01 MX MXPA03007694A patent/MXPA03007694A/es active IP Right Grant
- 2002-03-01 NZ NZ527261A patent/NZ527261A/en unknown
-
2003
- 2003-03-01 IL IL15709103A patent/IL157091A0/xx unknown
-
2004
- 2004-10-20 HK HK04108190A patent/HK1065334A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2437535A1 (fr) | 2002-09-12 |
| CA2437535C (fr) | 2011-05-10 |
| RU2003129163A (ru) | 2005-02-20 |
| EP1368474B1 (de) | 2007-01-17 |
| KR20030090655A (ko) | 2003-11-28 |
| CN1494591A (zh) | 2004-05-05 |
| JP4190291B2 (ja) | 2008-12-03 |
| EP1368474A1 (de) | 2003-12-10 |
| AU2002335492B2 (en) | 2006-11-02 |
| WO2002070700A1 (fr) | 2002-09-12 |
| RU2307666C2 (ru) | 2007-10-10 |
| FR2821624B1 (fr) | 2004-01-02 |
| CN1289670C (zh) | 2006-12-13 |
| DE60217651D1 (de) | 2007-03-08 |
| HUP0303312A2 (hu) | 2003-12-29 |
| PL204844B1 (pl) | 2010-02-26 |
| HK1065334A1 (en) | 2005-02-18 |
| HUP0303312A3 (en) | 2012-09-28 |
| KR100869190B1 (ko) | 2008-11-18 |
| MXPA03007694A (es) | 2004-03-16 |
| NZ527261A (en) | 2005-06-24 |
| US20040197783A1 (en) | 2004-10-07 |
| ES2279877T3 (es) | 2007-09-01 |
| FR2821624A1 (fr) | 2002-09-06 |
| IL157091A0 (en) | 2004-02-08 |
| DE60217651T2 (de) | 2007-10-18 |
| BR0207253A (pt) | 2004-02-10 |
| US7214533B2 (en) | 2007-05-08 |
| PL365226A1 (en) | 2004-12-27 |
| CZ20032670A3 (cs) | 2004-04-14 |
| JP2004527240A (ja) | 2004-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004022020D1 (de) | Oligomere verbindungen zur modulation der expression von survivin | |
| IL161016A (en) | Polypeptides capable of ang-2 binding | |
| ATE437652T1 (de) | Verwendung von hmgb1 zur aktivierung dendritischer zellen | |
| IL150168A0 (en) | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon | |
| DE69737814D1 (de) | Gekürzte lösliche typ-i-rezeptoren für tumor-nekrose-faktor | |
| DK1015586T3 (da) | TIE-receptortyrosinkinaseligandhomologer | |
| IL130036A0 (en) | Survivin a protein that inhibits cellular apoptosis and its modulation | |
| WO2003104418A3 (en) | RECONSTITUTED POLYPEPTIDES | |
| DE69838249D1 (de) | Anti-apo-2 antikörper | |
| EA200600591A1 (ru) | МОДУЛИРОВАНИЕ ЭКСПРЕССИИ eIF4E | |
| DE60207759D1 (de) | Pyrimidotriazine als phosphataseinhibitoren | |
| DE60217651D1 (de) | Zur modulation der krebszellenproliferation geeignetes polynukleotid | |
| DK1272457T3 (da) | Forbindelser til modulation af celleproliferation | |
| WO2002077263A3 (en) | Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon | |
| DE60325194D1 (de) | Methoden zur verwendung von lamellaren körpern für therapeutische zwecke | |
| DE60031856D1 (de) | Säugeradhäsionprotease | |
| DK0708831T3 (da) | Celletæthedsforstærkende proteintyrosinphosphataser | |
| DE60120410D1 (de) | Modulation der tetraspanin funktion | |
| DE69806107T2 (de) | Methoden und reagenzien zur regulierung von apoptosis | |
| ATE342975T1 (de) | Apoptosis induzierender faktor | |
| DE69739223D1 (de) | Oden und anwendungen | |
| ATE403665T1 (de) | Verfahren und zusammensetzungen zur modulierung der gluconeogenese mit pgc-1 | |
| WO2005019446A3 (en) | Novel form of protein tyrosine phosphatases and methods for identifying molecules binding thereto | |
| EA200500624A1 (ru) | Промотор для il-18bp, его получение и применение | |
| MY142798A (en) | Methods for preventing glyconoylation of proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |